Neurosolv Therapeutics

Neurosolve Therapeutics, an ethical enterprise headquartered in Belfast, Northern Ireland, and Baltimore, USA, has developed and patented Perineline™ to address spinal cord injuries. Glial scarring remains in the spinal cord after injury, blocking nerve signals transmitted to the body. Perineline™, a two-part treatment, allows signals to pass through the treated area, enabling functional recovery for the body and patients.